Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2)

  1. Blanco, J.-R.
  2. Alejos, B.
  3. Moreno, S.
Journal:
PLoS ONE

ISSN: 1932-6203

Year of publication: 2020

Volume: 15

Issue: 1

Type: Article

DOI: 10.1371/JOURNAL.PONE.0226724 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus